Ensysce Biosciences, Inc. (ENSC)

Ensysce Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	4	3	6	114	78	261
Market Cap Growth	-7.30%	-39.77%	-95.14%	46.40%	-70.11%	6.11%
Enterprise Value	0	3	7	119	82	263
PE Ratio	-	-0.31	-0.22	-3.81	1371.67	-25.79
PB Ratio	0.96	-10.33	-1.49	-14.47	-12.09	-39.02
P/FCF Ratio	-0.55	-0.31	-0.31	-13.83	-62.43	-278.53
P/OCF Ratio	-0.55	-0.31	-0.31	-13.83	-62.43	-278.53
EV/EBITDA Ratio	-0.26	-0.30	-0.28	-4.28	77.86	-28.74
EV/EBIT Ratio	-0.26	-0.30	-0.28	-4.28	77.88	-28.74
EV/FCF Ratio	-0.25	-0.28	-0.38	-14.43	-65.70	-280.97
Debt / Equity Ratio	0.07	-2.65	-1.19	-2.19	-0.66	-0.39
Debt / EBITDA Ratio	-0.02	-0.08	-0.18	-0.62	4.06	-0.29
Debt / FCF Ratio	-0.02	-0.08	-0.25	-2.09	-3.42	-2.80
Quick Ratio	2.14	0.37	0.36	0.77	0.03	0.07
Current Ratio	2.87	0.69	0.56	0.95	0.05	0.09
Interest Coverage	-6.21	-28.99	-219.70	-21.45	1.06	-9.53
Return on Equity (ROE)	-511.50%	-780.20%	1126.20%	1213.10%	2.70%	-485.50%
Return on Assets (ROA)	-266.10%	-262.40%	-290.90%	-327.40%	0.30%	-6.50%
Return on Capital (ROIC)	-250.31%	-2015.31%	-3365.91%	-212.84%	74.34%	211.31%
Earnings Yield	-320.27%	-318.64%	-453.03%	-26.22%	0.07%	-3.88%
FCF Yield	-293.50%	-323.25%	-322.96%	-7.23%	-1.60%	-0.36%
Buyback Yield / Dilution	-440.17%	-1158.34%	-114.15%	-22.15%	33.68%	-314.69%
Total Shareholder Return	-440.17%	-1158.34%	-114.15%	-22.15%	33.68%	-314.69%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).